Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis 2024-05-07 15:00
2024 World Brain Day Dedicated to Brain Health and Prevention 2024-05-07 14:45
GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024 2024-05-07 13:27
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC)as Monotherapy for Advanced Gastric Cancer 2024-05-07 08:12
HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications 2024-05-07 07:00
ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events 2024-05-06 23:25
Datasea Pre-Announces Estimated Revenue of $12.5 Million for April 2024 Supporting its Prior Revenue Guidance of $86 Million for Fiscal 2024 2024-05-06 22:00
German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications 2024-05-06 22:00
21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally 2024-05-06 15:53
Global Fitness Giant Anytime Fitness Celebrates 25-Club Milestone in Indonesia 2024-05-06 15:49
Healthplex Expo, Natural & Nutraceutical Products China 2024 to Shine in Shanghai in June 2024-05-06 13:29
Dr. Sarah Salvilla to lead new FWD HealthyMe business 2024-05-06 11:17
Alphamab Oncology to Present Chinese Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors for the First Time at the 2024 ASCO Annual Meeting 2024-05-06 10:25
Palm Oil Giant Musim Mas Pledges Third Tranche of S$5 million In Boost to Local Charities 2024-05-06 09:00
H2:iD HYDROGEN WATER ON THE GO™ PRESENTS GROUNDBREAKING APPROACH TO WELLNESS WITH NATURAL ENERGY BOOST 2024-05-06 09:00
World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus 2024-05-06 08:00
VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure 2024-05-04 18:00
United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024 2024-05-04 09:00
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease 2024-05-03 19:00
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement 2024-05-03 14:47
1 3.5 4.5 5.5 6.5 7.5 1508